Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Premedication for Less Invasive Surfactant Administration

To see complete record on, please visit this link

Id: NCT03735563

Organisation Name: University of Oulu

Overal Status: Recruiting

Start Date: February 11, 2019

Last Update: December 2, 2020

Lead Sponsor: University of Oulu

Brief Summary: Early respiratory management of preterm infants immediately after birth should be as gentle as possible. With this so-called developmental approach, unnecessary invasive methods can be avoided or at least postponed. This kind of "soft landing" allows cardiorespiratory transition with fewer adverse outcomes. Less invasive surfactant administration (LISA) is a technique that involves delivery of surfactant to a spontaneously breathing infant through a thin catheter. This technique minimizes the risk for neonatal lung injury caused by positive pressure ventilation. LISA is nowadays widely used in neonatal intensive care units (NICU). Although less invasive, newborns exposed to this procedure need premedication prior the procedure. There is no consensus, which drug would be the optimal premedication for LISA and the research on this topic is lacking. An ideal premedication would treat the procedural pain without suppressing the infant's own breathing. The sedation and analgesia should start fast but the effect should be short-acting with as few adverse effects as possible. The aim of this randomized, controlled trial (RCT) is to evaluate the feasibility, efficacy and safety of LISA protocol with the premedication of either ketamine or fentanyl by investigating whether one or the other is associated with lower rate of adverse events, hence would be preferred choice for premedication protocol.

  • Surfactant Deficiency Syndrome Neonatal

Total execution time in seconds: 0.33930015563965